Paraoxonase 1 gene polymorphisms in patients with type 2 diabetes mellitus

Paraoxonase 1 gene polymorphisms in patients with type 2 diabetes mellitus

The article deals with the features of lipid metabolism in patients with type 2 diabetes - the carriers of different genotypes of paraoxonase 1 gene. Known that the enzyme paraoxonase 1 (PON1) plays a key role in the regulation of lipid peroxidation and its activity is genetically determined. The in...

Full description

Bibliographic Details
Main Authors:	M. V. Kim, S. A. Skoryukova, A. A. Bystrova, E. I. Baranova, S. N. Pchelina
Format:	Article
Language:	Russian
Published:	Academician I.P. Pavlov First St. Petersburg State Medical University 2014-06-01
Series:	Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:	сахарный диабет дислипидемия атеросклероз сердечно-сосудистые заболевания ген параоксоназы 1 diabetes mellitus dyslipidemia atherosclerosis cardiovascular disease paraoxonase 1 gene
Online Access:	https://www.sci-notes.ru/jour/article/view/48

Similar Items

Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM)
by: M. V. Kim, et al.
Published: (2015-03-01)

Kardiovaskulyarnye narusheniya u detey pri sakharnom diabete
by: O A Dianov, et al.
Published: (2005-12-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients
by: R. G. Oganov, et al.
Published: (2008-12-01)

КЛИНИЧЕСКИЕ И ПРОГНОСТИЧЕСКИЕ АСПЕКТЫ МИКРОАЛЬБУМИНУРИИ У ЖИТЕЛЕЙ ГОРОДА ТВЕРИ
by: О. Б. Поселюгина
Published: (2014-12-01)

PREVENTIONAL SCREENING: ALL PROS AND CONTRAS
by: N. V. Pogosova, et al.
Published: (2016-06-01)

Guidelines on diabetes, pre-diabetes and cardiovascular diseases. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), 2007
by: Editorial team Diabetes Mellitus
Published: (2008-03-01)

Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels
by: S. A. Skoryukova, et al.
Published: (2015-06-01)

КОМОРБИДНОСТЬ ПАТОЛОГИИ ПАРОДОНТА И ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА
by: Ю.А. Сычева, et al.
Published: (2024-02-01)

PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE
by: M. N. Mamedov, et al.
Published: (2015-12-01)

Associations of cardiovascular diseases and type 2 diabetes with ophthalmic diseases in a population sample over 55 years old
by: A. O. Direev, et al.
Published: (2021-11-01)

FOLLOWING THE PROBLEM OF PROGNOSIS AND COURSE OF CARDIOVASCULAR DISEASES AND DIABETES
by: B. U. Mardanov, et al.
Published: (2015-02-01)

ДИСЛИПИДЕМИИ: ОБЗОР РЕКОМЕНДАЦИЙ ESC/EAS 2019 ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ. ЧАСТЬ 2 – ТАРГЕТНАЯ ТЕРАПИЯ
by: V. M. Pyrochkin, et al.
Published: (2021-05-01)

Statins and diabetes mellitus: risks and benefits
by: O. M. Drapkina, et al.
Published: (2012-12-01)

Evidence-based principles of early diagnostics of carbohydrate metabolism disturbances in the internal disease practice
by: E. A. Poddubskaya, et al.
Published: (2012-10-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
by: I. E. Chazova, et al.
Published: (2021-05-01)

Atherosclerosis pathogenesis from the perspective of microvascular dysfunction
by: D. M. Aronov, et al.
Published: (2021-11-01)

Pharmacoeconomical aspects of the treatment of arterial hypertension in patients with type II diabetes mellitus in outpatient department
by: J Sh Gushina, et al.
Published: (2009-03-01)

EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION
by: M. N. Kovrigina, et al.
Published: (2013-04-01)

Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older
by: L. A. Ratnikova, et al.
Published: (2012-08-01)

THE INFLUENCE OF SUBCLINICAL NEPHROPATHY ON THE SUBJECTIVE HEALTH’S EVALUATION OF PATIENTS WITH MELLITUS DIABETES
by: Maria Gennad’evna Evsina, et al.
Published: (2018-03-01)

Метаболические эффекты миметика глюкагоноподобного пептида-1 у больных сахарным диабетом 2-го типа в сочетании с кардиоваскулярной патологией
Published: (2016-12-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS
by: E. V. Akhmedova, et al.
Published: (2015-09-01)

КАРДИОЛОГИЧЕСКИЕ ПРОЯВЛЕНИЯ И ОСЛОЖНЕНИЯ МЕТАБОЛИЧЕСКОГО СИНДРОМА
by: Александр Владимирович Шабров, et al.
Published: (2022-01-01)

Issledovanie ONTARGET: Telmisartan ne ustupaet po effektivnosti ramiprilu u patsientov s vysokim riskom serdechno-sosudistykh oslozhneniy / sakharnym diabetom
by: Olga Konstantinovna Vikulova, et al.
Published: (2008-06-01)

Pathogenetic mechanisms of postmenopausal osteoporosis formation and their relationship with cardiovascular pathology
by: G. V. Poryadin, et al.
Published: (2022-04-01)

RISK FACTORS OF DAMAGE OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH PRIMARY OSTEOARTHRITIS WITH IDENTIFIED CORONARY ATHEROSCLEROSIS
by: S. M. Tsvinger, et al.
Published: (2018-12-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

Coffee and cardiovascular risk: what is new?
by: G. Ya. Maslennikova, et al.
Published: (2009-08-01)

Arterial calcification, atherosclerosis and osteoporosis: only clinical associations or a genetic platform?
by: I. A. Skripnikova, et al.
Published: (2021-11-01)

Assessment of calcification of the coronary arteries and long-term prognosis of cardiovascular disease
by: Y. V. Polonskaya, et al.
Published: (2020-04-01)

Ведение пациента с семейной комбинированной гиперлипидемией на примере клинического случая
by: Olha Babii, et al.
Published: (2019-06-01)

Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa
by: Marina Vladimirovna Shestakova, et al.
Published: (2008-03-01)

ROL' tsITOKINOV V RAZVITII SERDEChNO-SOSUDISTyKh ZABOLEVANIY I OSTEOPOROZA
by: O. B. ERShOVA, et al.
Published: (2011-12-01)

Modern Aspects of the Clinic, Diagnosis and Treatment of Prediabetes
by: N. V. Pyrikova, et al.
Published: (2020-10-01)

Nutrition as one of the important factors in prevention and treatment of atherosclerotic cardiovascular diseases
by: I. V. Rudchenko, et al.
Published: (2020-07-01)

Long-term low-dose atorvastatin therapy and prevention of macroangiopathy complications in elderly patients with Type 2 diabetes mellitus
by: G. A. Batrak, et al.
Published: (2010-06-01)

Sakharnyy diabet 2 tipa, arterial'naya gipertenziya i risk serdechno-sosudistykh oslozhneniy
by: O A Kislyak, et al.
Published: (2008-03-01)

Plant stanol ethers: perspectives and effects in non-pharmaceutical prevention of atherosclerotic cardiovascular pathology
by: N. V. Perova
Published: (2006-12-01)